Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase EARLY_PHASE1 1Phase 1 1

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 6Breast 3CNS 2Gynecologic 1

Conditions

Breast Neoplasms 3Radiation Fibrosis Syndrome 1Peripheral Nervous System Diseases 1Inflammation 1Fibrosis 1Camurati-Engelmann Syndrome 1

Interventions

Trastuzumab 349Paclitaxel 310Cyclophosphamide 286Docetaxel 267Carboplatin 215Capecitabine 214Letrozole 185Fulvestrant 178Doxorubicin 166Bevacizumab 136Anastrozole 120Tamoxifen 117pertuzumab 114pembrolizumab 113Epirubicin 110exemestane 107Vinorelbine 106Gemcitabine 106Albumin-Bound Paclitaxel 92Lapatinib 84130-nm albumin-bound paclitaxel 83Radiotherapy 79palbociclib 75eribulin 73Cisplatin 69pyrotinib 66Taxes 65Everolimus 55Goserelin 50Drug Therapy 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Losartan × Breast × Clear all
NCT05637216 2026-04-24

Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients

Shaw Cancer Center

Phase 2 Recruiting
43 enrolled
Breast

Radiation Fibrosis Syndrome, Breast Neoplasms, Camurati-Engelmann Syndrome, Fibrosis, Inflammation

NCT06135493 2025-04-24

Prevention of Paclitaxel-induced Peripheral Neuropathy in Breast Cancer Patients

Future University in Egypt

Phase 2 Completed
84 enrolled
Breast

Breast Neoplasms, Peripheral Nervous System Diseases

NCT05097248 2021-10-28

Camrelizumab in Combination With PLD and Losartan in Patients With TNBC Who Have Received ≦ 1 Line of Chemotherapy

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase 2 Unknown
52 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡